Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $10.7 Million - $12.2 Million
-47,600 Reduced 73.46%
17,200 $4.3 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $7.14 Million - $9 Million
38,600 Added 147.33%
64,800 $15 Million
Q3 2023

Nov 15, 2023

SELL
$233.08 - $265.59 $326,312 - $371,825
-1,400 Reduced 5.07%
26,200 $6.5 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $6.21 Million - $7.07 Million
27,600 New
27,600 $6.62 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $469,414 - $2.86 Million
1,900 Added 55.88%
5,300 $1.37 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $806,174 - $1.02 Million
3,400 New
3,400 $860,000
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $823,264 - $1.01 Million
-3,200 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $934,656 - $1.05 Million
3,200 New
3,200 $1.05 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $182B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.